ASX:BIT

Biotron (BIT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.03 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.08%
Price Target
N/A
BIT stock logo

About Biotron Stock (ASX:BIT)

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

BIT Stock News Headlines

BBC micro:bit playground survey
Truth about Trump you’ve never heard
Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump.
Truth about Trump you’ve never heard
Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump.
The Best Multi-Bit Screwdriver
BBC micro:bit - the next gen
Biotron Limited (BIT.AX)
Biotron Drug Effective Against COVID-19 In Animals
See More Headlines
Receive BIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-4,020,000.00
Net Margins
-244.54%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.65 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.59
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Michelle Miller BSc.
    GCertAppFin, MSc., Ph.D., MD & Executive Director
  • Mr. Peter James Nightingale B.Econ (Age 67)
    CA, Company Secretary
    Comp: $120k
  • Dr. Stephen L. Becker M.D.
    Chief Medical Officer

BIT Stock Analysis - Frequently Asked Questions

This page (ASX:BIT) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners